Effects of therapy with [177Lu-DOTA0,Tyr 3]octreotate on endocrine function

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 11, 2009, Pages 1758-1766

  Teunissen, Jaap J M ^a   Krenning, Eric P ^a   De Jong, Frank H ^a   De Rijke, Yolanda B ^a   Feelders, Richard A ^a   Van Aken, Maarten O ^a   De Herder, Wouter W ^a   Kwekkeboom, Dik J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antibodies; Endocrinology; Oncology; Peptide; Radiolabelled peptides; Radiopharmacy; Somatostatin; Therapy; Tumour targeting

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID OCTREOTIDE[3 TYROSINE] LUTETIUM 177; 3,3',5' TRIIODOTHYRONINE; CORTICOSTEROID; FOLLITROPIN; HEMOGLOBIN A1C; INHIBIN B; LUTEINIZING HORMONE; LUTETIUM 177; OCTREOTIDE[3 TYROSINE]; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; THYROTROPIN; UNCLASSIFIED DRUG; (177LUTETIUM DOTA(O)TYR3)OCTREOTATE; (177LUTETIUM-DOTA(O)TYR3)OCTREOTATE; DRUG DERIVATIVE; GLUCOSE; HORMONE; OCTREOTIDE; ORGANOMETALLIC COMPOUND; RECEPTOR; SOMATOSTATIN;

ADULT; AGED; ARTICLE; BONE METASTASIS; CONTROLLED STUDY; ENDOCRINE FUNCTION; FEMALE; GASTRINOMA; GLUCOSE HOMEOSTASIS; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHYROIDISM; INSULINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS TUMOR; PARAGANGLIOMA; SCINTISCANNING; THYROID CARCINOMA; THYROID MEDULLARY CARCINOMA; BLOOD; CHEMISTRY; ENDOCRINE GLAND; HOMEOSTASIS; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION EXPOSURE; RETROSPECTIVE STUDY; TIME;

ADULT; AGED; ENDOCRINE GLANDS; FEMALE; GLUCOSE; HOMEOSTASIS; HORMONES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASMS; OCTREOTIDE; ORGANOMETALLIC COMPOUNDS; RECEPTORS, PEPTIDE; RETROSPECTIVE STUDIES; SOMATOSTATIN; TIME FACTORS; YOUNG ADULT;

EID: 72149100177     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1151-8     Document Type: Article

References (39)

1. L Bodei M Cremonesi S Zoboli C Grana M Bartolomei P Rocca, et al. 2003 Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study Eur J Nucl Med Mol Imaging 30 207 216 1:CAS:528:DC%2BD3sXms1CnsQ%3D%3D 12552338
2. C Waldherr M Pless HR Mäcke T Schumacher A Crazzolara EU Nitzsche, et al. 2002 Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC J Nucl Med 43 610 616 1:CAS:528:DC%2BD38XktlOltbk%3D 11994522
3. DJ Kwekkeboom J Müller-Brand G Paganelli LB Anthony S Pauwels LK Kvols, et al. 2005 Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs J Nucl Med 46 62S 6S 1:CAS:528:DC%2BD2MXhsVeksLs%3D 15653653
4. C Waldherr M Pless HR Mäcke A Haldemann J Müller-Brand 2001 The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II study Ann Oncol 12 941 945 10.1023/A:1011160913619 1:STN:280:DC%2BD3MvnvVehsw%3D%3D 11521799 (Pubitemid 32725766)
5. DJ Kwekkeboom JJ Teunissen WH Bakker PP Kooij WW de Herder RA Feelders, et al. 2005 Radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors J Clin Oncol 23 2754 2762 10.1200/JCO.2005.08.066 1:CAS:528:DC%2BD2MXktleqtrk%3D 15837990 (Pubitemid 46179465)
6. S Moll V Nickeleit J Müller-Brand FP Brunner HR Mäcke MJ Mihatsch 2001 A new cause of renal thrombotic microangiopathy: yttrium 90-DOTATOC internal radiotherapy Am J Kidney Dis 37 847 851 10.1016/S0272- 6386(01)80135-9 1:STN:280:DC%2BD3M3msFOhsg%3D%3D 11273886
7. MP Stoffel M Pollok J Fries CA Baldamus 2001 Radiation nephropathy after radiotherapy in metastatic medullary thyroid carcinoma Nephrol Dial Transplant 16 1082 1083 10.1093/ndt/16.5.1082 1:STN:280:DC%2BD3Mzotlemtw%3D%3D 11328930
8. M Cybulla SM Weiner A Otte 2001 End-stage renal disease after treatment with 90Y-DOTATOC Eur J Nucl Med 28 1552 1554 10.1007/s002590100599 1:CAS:528:DC%2BD3MXmvFSlu7g%3D 11685499
9. EJ Rolleman R Valkema M de Jong PP Kooij EP Krenning 2003 Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine Eur J Nucl Med Mol Imaging 30 9 15 10.1007/s00259-002-0982-3 1:CAS:528:DC%2BD38XpsV2iurY%3D 12483404 (Pubitemid 36692887)
10. N Kimura M Schindler N Kasai I Kimura 2001 Immunohistochemical localization of somatostatin receptor type 2A in rat and human tissues Endocr J 48 95 102 10.1507/endocrj.48.95 1:CAS:528:DC%2BD3MXjvVCltL8%3D 11403108 (Pubitemid 32230390)
11. MC Zatelli EC degli Uberti 2004 Somatostatin receptors: from basic science to clinical approach-thyroid Dig Liver Dis 36 S86 S92 10.1016/j.dld.2003.11.018 1:CAS:528:DC%2BD2cXjsFOnsrY%3D 15077916 (Pubitemid 41115495)
12. N Baou M Bouras JP Droz M Benahmed S Krantic 2000 Evidence for a selective loss of somatostatin receptor subtype expression in male germ cell tumors of seminoma type Carcinogenesis 21 805 810 10.1093/carcin/21.4.805 1:CAS:528:DC%2BD3cXivFKku74%3D 10753219
13. A Sasaki K Yoshinaga 1989 Immunoreactive somatostatin in male reproductive system in humans J Clin Endocrinol Metab 68 996 999 10.1210/jcem-68-5-996 1:CAS:528:DyaL1MXktVWisLY%3D 2565916
14. R Södergård T Bäckström V Shanbhag H Carstensen 1982 Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature J Steroid Biochem 16 801 810 10.1016/0022-4731(82)90038-3 7202083 (Pubitemid 13228095)
15. TJ Visser R Docter G Hennemann 1977 Radioimmunoassay of reverse tri-iodothyronine J Endocrinol 73 395 396 10.1677/joe.0.0730395 1:CAS:528:DyaE2sXkvVSksLo%3D 864376
16. SJ Standing RP Taylor 1992 Glycated haemoglobin: an assessment of high capacity liquid chromatographic and immunoassay methods Ann Clin Biochem 29 5 494 505 1:CAS:528:DyaK3sXjtlKi 1280025
17. M Druckenthaner C Schwarzer C Ensinger M Gabriel R Prommegger G Riccabona, et al. 2007 Evidence for somatostatin receptor 2 in thyroid tissue Regul Pept 138 32 39 10.1016/j.regpep.2006.08.005 1:CAS:528: DC%2BD2sXhtF2qtg%3D%3D 16996150 (Pubitemid 44918128)
18. JC Reubi B Waser JC Schaer JA Laissue 2001 Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands Eur J Nucl Med 28 836 846 10.1007/s002590100541 1:CAS:528:DC%2BD3MXkvVWltL0%3D 11504080 (Pubitemid 32662546)
19. J Fombonne Z Csaba Y von Boxberg A Valayer C Rey M Benahmed, et al. 2003 Expression of somatostatin receptor type-2 (sst2A) in immature porcine Leydig cells and a possible role in the local control of testosterone secretion Reprod Biol Endocrinol 1 19 10.1186/1477-7827-1-19 12646058 (Pubitemid 39130505)
20. LJ Hofland SW Lamberts PM van Hagen JC Reubi J Schaeffer M Waaijers, et al. 2003 Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs J Nucl Med 44 1315 1321 1:CAS:528:DC%2BD3sXntFyruro%3D 12902423
21. RT Chlebowski D Heber 1982 Hypogonadism in male patients with metastatic cancer prior to chemotherapy Cancer Res 42 2495 2498 1:STN:280: DyaL387osValsQ%3D%3D 7074625
22. HE Turner JA Wass 1997 Gonadal function in men with chronic illness Clin Endocrinol (Oxf) 47 379 403 10.1046/j.1365-2265.1997.2611108.x 1:STN:280:DyaK1c%2FmvVantA%3D%3D
23. W de Ronde YT van der Schouw FH Pierik HA Pols M Muller DE Grobbee, et al. 2005 Serum levels of sex hormone-binding globulin (SHBG) are not associated with lower levels of non-SHBG-bound testosterone in male newborns and healthy adult men Clin Endocrinol (Oxf) 62 498 503 10.1111/j.1365-2265.2005.02252.x
24. O Ukkola J Gagnon T Rankinen PA Thompson Y Hong AS Leon, et al. 2001 Age, body mass index, race and other determinants of steroid hormone variability: the HERITAGE Family Study Eur J Endocrinol 145 1 9 10.1530/eje.0.1450001 1:CAS:528:DC%2BD3MXlt1Ghu7Y%3D 11415846
25. H Cavaliere N Abelin G Medeiros-Neto 1988 Serum levels of total testosterone and sex hormone binding globulin in hypothyroid patients and normal subjects treated with incremental doses of L-T4 or L-T3 J Androl 9 215 219 1:CAS:528:DyaL1cXks1Ons7c%3D 3403362
26. M Wichers E Benz H Palmedo HJ Biersack F Grünwald D Klingmüller 2000 Testicular function after radioiodine therapy for thyroid carcinoma Eur J Nucl Med 27 503 507 10.1007/s002590050535 1:CAS:528:DC%2BD3cXis1Oqsbc%3D 10853804
27. PW Rosário AL Barroso LL Rezende EL Padrão MA Borges VC Guimarães, et al. 2006 Testicular function after radioiodine therapy in patients with thyroid cancer Thyroid 16 667 670 10.1089/thy.2006.16.667 16889490 (Pubitemid 44246261)
28. DJ Handelsman JR Turtle 1983 Testicular damage after radioactive iodine (I-131) therapy for thyroid cancer Clin Endocrinol (Oxf) 18 465 472 10.1111/j.1365-2265.1983.tb02876.x 1:STN:280:DyaL3s3lvFOqtQ%3D%3D
29. AM Sawka DC Lakra J Lea B Alshehri RW Tsang JD Brierley, et al. 2008 A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors Clin Endocrinol (Oxf) 69 479 490 10.1111/j.1365-2265.2008.03222.x
30. BD Anawalt RA Bebb AM Matsumoto NP Groome PJ Illingworth AS McNeilly, et al. 1996 Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction J Clin Endocrinol Metab 81 3341 3345 10.1210/jc.81.9.3341 1:CAS:528:DyaK28Xls1OrtLw%3D 8784094 (Pubitemid 26296213)
31. FJ Hayes N Pitteloud S DeCruz WF Crowley Jr PA Boepple 2001 Importance of inhibin B in the regulation of FSH secretion in the human male J Clin Endocrinol Metab 86 5541 5546 10.1210/jc.86.11.5541 1:CAS:528: DC%2BD3MXos1KqtLg%3D 11701733 (Pubitemid 33070286)
32. TK Jensen AM Andersson NH Hjollund T Scheike H Kolstad A Giwercman, et al. 1997 Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men J Clin Endocrinol Metab 82 4059 4063 10.1210/jc.82.12.4059 1:CAS:528:DyaK2sXnvFykt70%3D 9398713
33. FH Pierik JT Vreeburg T Stijnen FH De Jong RF Weber 1998 Serum inhibin B as a marker of spermatogenesis J Clin Endocrinol Metab 83 3110 3114 10.1210/jc.83.9.3110 1:CAS:528:DyaK1cXmt1ehtbY%3D 9745412 (Pubitemid 28500943)
34. DJ Kwekkeboom FH de Jong AM van Hemert JP Vandenbroucke HA Valkenburg SW Lamberts 1990 Serum gonadotropins and alpha-subunit decline in aging normal postmenopausal women J Clin Endocrinol Metab 70 944 950 10.1210/jcem-70-4-944 1:CAS:528:DyaK3cXit12qtLg%3D 1690750
35. RP Peeters PJ Wouters H van Toor E Kaptein TJ Visser G Van den Berghe 2005 Serum 3,3′,5′-triiodothyronine (rT3) and 3,5,3′- triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities J Clin Endocrinol Metab 90 4559 4565 10.1210/jc.2005-0535 1:CAS:528:DC%2BD2MXnvVWltbg%3D 15886232 (Pubitemid 41159343)
36. RI Dorin CR Qualls LM Crapo 2003 Diagnosis of adrenal insufficiency Ann Intern Med 139 194 204 12899587
37. TA Abdu TA Elhadd R Neary RN Clayton 1999 Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease J Clin Endocrinol Metab 84 838 843 10.1210/jc.84.3.838 1:CAS:528:DyaK1MXhvFegtLw%3D 10084558
38. M Schmiegelow U Feldt-Rasmussen AK Rasmussen M Lange HS Poulsen J Müller 2003 Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor J Clin Endocrinol Metab 88 3149 3154 10.1210/jc.2002-021994 1:CAS:528: DC%2BD3sXlslait78%3D 12843158 (Pubitemid 36877487)
39. Y Taniyama T Suzuki Y Mikami T Moriya S Satomi H Sasano 2005 Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study Endocr J 52 605 611 10.1507/endocrj.52.605 1:CAS:528: DC%2BD28Xjs1Cguw%3D%3D 16284440 (Pubitemid 41609051)